Merck Ventures Further into Natural Killer Therapies with US$1.9 B Artiva Alliance

By Michelle Liu

Pharma Deals Review: Vol 2021 Issue 2 (Table of Contents)

Published: 13 Feb-2021

DOI: 10.3833/pdr.v2021.i2.2593     ISSN: 1756-7874

Section: Research & Development



In a move to bolster its immuno-oncology portfolio, Merck & Co...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details